View Archive »
About The Cover
Representative images of immunohistochemical staining for Extracellular Sulfatase Sulf-2 (SULF2) in pediatric Glioblastoma (GBM). See Phillips et al.
|
|
Table of Contents
|
| Targeting ProteinTyrosine Phosphatases in Breast Cancer |
|
https://doi.org/10.18632/oncotarget.496
Nicola Aceto, and Mohamed Bentires-Alj
|
| 514-515 |
|
| Voltagedependent K+ channels as oncotargets in malignant gliomas |
|
https://doi.org/10.18632/oncotarget.514
Florence Lefranc, Henri-Benjamin Pouleau, Michal Rynkowski, and Olivier De Witte
|
| 516-517 |
Brief Reports
|
| A novel cooperative mechanism linking TGFβ and Lyn kinase activation to imatinib resistance in chronic myeloid leukaemia cells |
|
https://doi.org/10.18632/oncotarget.500
Andrew Chantry, Paul G Smith, and Hideo Tanaka
|
| 518-524 |
Research Papers
|
| The Hsp90 inhibitor NVPAUY922AG inhibits NFκB signaling overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells |
|
https://doi.org/10.18632/oncotarget.491
Elisabeth J. Walsby, Laurence Pearce, Alan K. Burnett, Chris Fegan, and Chris Pepper
|
| 525-534 |
|
| A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the BMYB/MYCN axis in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.498
Francesco Sottile, Ilaria Gnemmi, Sandra Cantilena, Walter C. D'Acunto, and Arturo Sala
|
| 535-545 |
|
| Dramatic reduction of sequence artefacts from DNA isolated from formalinfixed cancer biopsies by treatment with uracilDNA glycosylase |
|
https://doi.org/10.18632/oncotarget.503
Hongdo Do, and Alexander Dobrovic
|
| 546-558 |
Research Perspectives
|
| Solid Tumor Differentiation Therapy – Is It Possible |
|
https://doi.org/10.18632/oncotarget.512
Filemon Dela cruz, and Igor Matushansky
|
| 559-567 |
|
| Novel Therapeutic Targets in the Brain Tumor Microenvironment |
|
https://doi.org/10.18632/oncotarget.526
Joanna J. Phillips
|
| 568-575 |
|
| FLT3 in lineage specification and plasticity |
|
https://doi.org/10.18632/oncotarget.499
Sarah Greenblatt, and Donald Small
|
| 576-580 |
|
| Cellbased highthroughput screens for the discovery of chemotherapeutic agents |
|
https://doi.org/10.18632/oncotarget.513
Jennifer T Fox, and Kyungiae Myung
|
| 581-585 |
Methodological Reports
|
| Mantle cell lymphomalike lymphomas in cmyc3’RR/p53+/ mice and cmyc3’RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin |
|
https://doi.org/10.18632/oncotarget.474
Pauline Rouaud, Rémi Fiancette, Christelle Vincent-Fabert, Virginie Magnone, Michel Cogné, Pierre Dubus, and Yves Denizot
|
| 586-593 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
